Safety and Efficacy of Ixekizumab in Chinese Adults with Moderate-to-Severe Plaque Psoriasis: A Prospective, Multicenter, Observational Study

被引：0
|
作者：
Li Ying
Ji Suyun
Liang Yanhua
Liang Yunsheng
Deng Li
Dang Lin
Lv Chengzhi
Lin Bingjiang
Zhang Furen
Shi Wendi
Li Jinnan
Dong Yu
Dou Guanshen
Yuling Shi
机构：
[1] Tongji University School of Medicine,Department of Dermatology, Shanghai Skin Disease Hospital
[2] Southern Medical University,Department of Dermatology, Dermatology Hospital
[3] Southern Medical University,Department of Dermatology, Cosmetology and Venereology, Shenzhen Hospital
[4] Longgang Central Hospital of Shenzhen,Department of Dermatology
[5] Dalian Skin Disease Hospital,Department of Dermatology
[6] Ningbo First Hospital,Department of Dermatology
[7] Shandong First Medical University & Shandong Academy of Medical Sciences,Shandong Provincial Hospital for Skin Diseases & Shandong Provincial Institute of Dermatology and Venereology
[8] Eli Lilly and Company,undefined
来源：
Advances in Therapy | 2023年 / 40卷
关键词：
Efficacy; Ixekizumab; Psoriasis; Real world; Safety;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：5464 / 5474
页数：10
相关论文
共 50 条
  • [41] The real world impact of adalimumab on quality of life and the physical and psychological effects of moderate-to-severe psoriasis: a UK prospective, multicenter, observational study
    Leman, Joyce
    Walton, Shernaz
    Layton, Alison M.
    Ward, Kathleen A.
    McBride, Sandy
    Cliff, Sandeep
    Downs, Anthony
    Landeira, Margarita
    Bewley, Anthony
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2020, 31 (03) : 213 - 221
  • [42] Safety and efficacy of etanercept monotherapy for moderate-to-severe plaque psoriasis: A prospective 12-week follow-up study
    Fang Xie
    Rui Wang
    Zi-gang Zhao
    Xian-fu Meng
    Bi-wen Lin
    Jie Yang
    Wen-juan Wang
    Xiang-yu Ding
    Yi Yang
    Hua Zhao
    Cheng-xin Li
    Heng-jin Li
    Yong Zhou
    Current Medical Science, 2017, 37 : 943 - 947
  • [43] Efficacy and safety of ixekizumab treatment in Japanese patients with moderate-to-severe plaque psoriasis: Subgroup analysis of a placebo-controlled, phase 3 study (UNCOVER-1)
    Imafuku, Shinichi
    Torisu-Itakura, Hitoe
    Nishikawa, Atsushi
    Zhao, Fangyi
    Cameron, Gregory S.
    JOURNAL OF DERMATOLOGY, 2017, 44 (11) : 1285 - 1290
  • [44] Safety and efficacy of etanercept monotherapy for moderate-to-severe plaque psoriasis: A prospective 12-week follow-up study
    Xie, Fang
    Wang, Rui
    Zhao, Zi-gang
    Meng, Xian-fu
    Lin, Bi-wen
    Yang, Jie
    Wang, Wen-juan
    Ding, Xiang-yu
    Yang, Yi
    Zhao, Hua
    Li, Cheng-xin
    Li, Heng-jin
    Zhou, Yong
    JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL SCIENCES, 2017, 37 (06) : 943 - 947
  • [45] Safety and Efficacy of Etanercept Monotherapy for Moderate-to-severe Plaque Psoriasis:A Prospective 12-week Follow-up Study
    解方
    王睿
    赵梓纲
    孟宪芙
    林碧雯
    杨洁
    王文娟
    丁香玉
    杨怡
    赵华
    李承新
    李恒进
    周勇
    Current Medical Science, 2017, 37 (06) : 943 - 947
  • [46] The management of moderate-to-severe chronic plaque psoriasis
    Tonini, Annalisa
    Panduri, Salvatore
    D'Erme, Angelo M.
    Papadia, Francesca
    Romaneli, Marco
    Krueger, James G.
    Chiricozzi, Andrea
    GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA, 2017, 152 (05): : 447 - 457
  • [47] Guselkumab in the treatment of moderate-to-severe plaque psoriasis
    Lopez-Sanchez, Cristina
    Puig, Lluis
    IMMUNOTHERAPY, 2020, 12 (06) : 355 - 371
  • [48] Population pharmacokinetic and exposure-efficacy analysis of ixekizumab in paediatric patients with moderate-to-severe plaque psoriasis (IXORA-PEDS)
    Jackson, Kimberley
    Chua, Laiyi
    de Mendizabal, Nieves Velez
    Pitou, Celine
    Capriles, Claudia Rodriguez
    Paller, Amy S.
    Lansang, Perla
    Seyger, Marieke M. B.
    Papp, Kim
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 88 (03) : 1074 - 1086
  • [49] Ixekizumab for the treatment of pediatric patients with moderate to severe plaque psoriasis
    Cather, Jennifer Clay
    Young, Chaney T.
    Young, Melody S.
    Cather, J. Christian
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2021, 21 (08) : 983 - 990
  • [50] Understanding efficacy-safety balance of biologics in moderate-to-severe pediatric psoriasis
    Golhen, Klervi
    Winskill, Carolyn
    Theiler, Martin
    Buettcher, Michael
    Yeh, Yu-Hsin
    Zhang, Nancy
    Welzel, Tatjana
    Pfister, Marc
    FRONTIERS IN MEDICINE, 2022, 9
12345